Dr. Khaled Almosa is a leading Saudi biotechnology pioneer and senior management consultant. Recognized as the “Godfather of Biotechnology Manufacturing in Saudi Arabia” by H.E. Dr. Hussein A. Gezairy (former WHO Regional Director and former Saudi Minister of Health), he has shaped the Kingdom’s life sciences and healthcare industries for more than three decades.

 Government, Policy & Innovation Leadership

He served as a member of the Supreme Committee for Research, Development & Innovation (2021–2024), chaired by HRH the Crown Prince at the Council of Economic and Development Affairs. His contributions helped shape national strategies in biotechnology, healthcare, and R&D.

Executive Profile

Dr. Almosa is the first Saudi national to invest in and establish biotechnology manufacturing industries, founding companies across insulin and biologics production, human and animal vaccines, biomedical engineering, medical services, consulting, and R&D. His work directly advances Saudi Vision 2030 through healthcare localization, innovation, and workforce development.

Pioneering Biotech Enterprises

Dr. Almosa founded and led several landmark companies that form the backbone of Saudi Arabia’s biotechnology ecosystem:

• SAUDI BIO (2010–2020) — Founder & Chairman
  First and only Saudi manufacturer of insulin and biologics, in partnership with Novo Nordisk and Sandoz. Acquired in 2023 by Lifera (PIF-owned).
• Vaccine Industrial Holding Company (VIC) — Founder & Chairman
  Home to Saudi Arabia’s first and the Middle East’s largest human vaccine manufacturing facility, partnering with CSL Seqirus and other global biotech leaders.
• Biotech Innovation Company for R&D — Founder & Chairman
  Established with Baylor College of Medicine; collaborates with KACST; funded by Saudi NIH to conduct MERS clinical trials.
• Anivax — Founder & Chairman
  A dedicated animal vaccine R&D and manufacturing company in partnership with Boehringer Ingelheim, positioning Saudi Arabia as a regional veterinary biotech hub.
• Bioera — Industrial Engineering & Project Management — Founder & Chairman
  International engineering firm operating across the GCC, USA, Europe, and India with partners including KeyPlants, Zyme Biotech, Shahin Engineering, Podtech, and Jadwa Contractors.
• MedTech Group of Companies — Founder & Chairman
  Operates day surgery centers, medical facilities, and medical supplies services in Riyadh.
• Biotechnology Training Institute — Founder
  Being established with NIBRT, the first institute of its kind in the Middle East to train the region’s biotechnology workforce.

Consulting & Strategic Advisory

A certified senior management consultant, Dr. Almosa advises on healthcare management, biotech strategy, investment, and business development.

• Dr. Khaled Almosa Consulting Firm (Riyadh) — Chairman
  Licensed by the Saudi Ministry of Commerce; specializes in biotech, R&D, investment, and business development.
• Averon Consulting (Dubai) — Chairman
  Provides strategic advisory in healthcare and biotechnology, including regulatory strategy, market entry, partnerships, and innovation planning.

Research & Publications

Dr. Almosa led influential research on vaccine manufacturing sustainability in Saudi Arabia, including the study:
“Investigating Factors That Impede Successful Vaccine Manufacturing Business in the Kingdom of Saudi Arabia: Imperatives for Healthcare Sustainability.”

He is also the author of:
“My Mission to Save Lives in Saudi Arabia: Empowering 2030 Through Local Manufacturing of Insulin, Vaccines, Cancer Therapeutics, and Gene Editing Technologies.”

Legacy

Dr. Almosa’s legacy is the biotechnology ecosystem he built — from the first insulin factory to the first human vaccine plant, from pioneering R&D to training the next generation of biotech professionals. His career represents a mission to save lives, strengthen national health security, and secure the Kingdom’s biotechnological future.